PAR-25-321 - Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Expired NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications. | NOT-EB-23-002 | NIBIB, NCCIH, NCI, NHLBI, NIA, NIAID, NICHD, NIGMS | Apr 14, 2023 | Sep 9, 2025 | R01, R21, R35, R41/R42, R43/R44 |
For technical issues E-mail OER Webmaster